JINGYI DUAN: Open Payments
NPI 1699108829 · STUART, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,135 in 18 payments from 6 companies in 2025. Trend: 2023 $38 · 2024 $1,159 · 2025 $1,135
Food & beverage: $1,135
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $307 |
| ABBVIE INC. | 6 | $256 |
| Mallinckrodt Hospital Products Inc. | 2 | $171 |
| Regeneron Healthcare Solutions, Inc. | 3 | $153 |
| Madrigal Pharmaceuticals | 1 | $129 |
| Gilead Sciences, Inc. | 1 | $119 |
Products named: XIFAXAN, TERLIVAZ, DUPIXENT, RINVOQ, REZDIFFRA, SKYRIZI, Livdelzi.
Industry payments across FL — which companies pay providers there.
